Clinical Trial

Voice Analysis for Monitoring Patients With Heart Failure

Study acronym: VAMP-HF
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated September 2024 completion). Its status may not reflect the trial's current state.
Summary
This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.
Trial Details
NCT Number NCT06566911
Lead Sponsor Noah Labs
Collaborators: Charite University, Berlin, Germany, Mayo Clinic
Conditions Heart Failure
Enrollment 70 participants
Start Date 2024-01-24
Primary Completion 2024-09 (estimated)
Study Completion 2024-09 (estimated)
Updated on ClinicalTrials.gov 2024-08-22